TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25108589

Group type: EXPERIMENTAL
Intervention: Dysphonic speakers
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal controls
Number of subjects: 40
Study: 23417625

Group type: EXPERIMENTAL
Intervention: Social Skills Training Group-based Program (SST-GP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Leisure Activities Group-based Program (LA-GP)
Number of subjects: 0
Study: 21321791

Group type: EXPERIMENTAL
Intervention: 99mTc-besilesomab (Scintimun)
Number of subjects: 119

Group type: COMPARATOR
Intervention: 99mTc-HMPAO-labelled white blood cells (WBCs)
Number of subjects: 119
Study: 19376310

Group type: EXPERIMENTAL
Intervention: Fondaparinux
Number of subjects: 20078

Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 20078
Study: 17845881

Group type: EXPERIMENTAL
Intervention: Home-walking exercise prescription
Number of subjects: 103
Study: 14718430

Group type: EXPERIMENTAL
Intervention: Cervicomandibular support collar (CMSC)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Nasal continuous positive airway pressure (nCPAP)
Number of subjects: 10
Study: 11294692

Group type: EXPERIMENTAL
Intervention: Exercise (90 min of brisk walking the day before)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Control (no exercise)
Number of subjects: 11
Study: 9391992

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (50 micrograms) biweekly
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (100 micrograms) biweekly
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tibolone 2.5 mg/day
Number of subjects: 30

Group type: COMPARATOR
Intervention: GH-RH stimulation test
Number of subjects: 30
Study: 8934730

Group type: EXPERIMENTAL
Intervention: Infusional 5-FU
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Infusional 5-FU with leucovorin or interferon
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Time-modulated infusional 5-FU
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bolus single agent 5-FU
Number of subjects: 0
Study: 2212256

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 40
Study: 340942

Group type: EXPERIMENTAL
Intervention: Sulfinpyrazone (200 mg four times a day)
Number of subjects: 1475

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1475
Study: 30806758

Group type: EXPERIMENTAL
Intervention: IRI/CDDP (IRI, 60 mg/m2; CDDP, 30 mg/m2, q2w)
Number of subjects: 108

Group type: COMPARATOR
Intervention: IRI (150 mg/m2, q2w)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: IRI/CDDP
Number of subjects: 108

Group type: COMPARATOR
Intervention: IRI
Number of subjects: 108
Study: 28882634

Group type: EXPERIMENTAL
Intervention: Continuous theta burst stimulation (cTBS) applied over M1 on Day 1 during reinforcement learning
Number of subjects: 50

Group type: COMPARATOR
Intervention: Continuous theta burst stimulation (cTBS) applied over M1 on Day 3 after consolidation
Number of subjects: 50

Group type: COMPARATOR
Intervention: cTBS applied on Day 2 in a recent study (Derosiere et al., 2017)
Number of subjects: 50
Study: 24616488

Group type: EXPERIMENTAL
Intervention: Test light (515 nm) after exposure to longer wavelength light (589 nm)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Test light (515 nm) after exposure to shorter wavelength light (461 nm)
Number of subjects: 16
Study: 22176808

Group type: EXPERIMENTAL
Intervention: 20% mannitol (1 g/kg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 23.4% hypertonic saline (0.686 mL/kg)
Number of subjects: 8
Study: 19997098

Group type: EXPERIMENTAL
Intervention: Sublingual administration of a single dose of testosterone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (belief of receiving testosterone)
Number of subjects: 0
Study: 18996862

Group type: EXPERIMENTAL
Intervention: Experimental modified starch therapy (100 g digestible starch)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Traditional uncooked cornstarch therapy (100 g)
Number of subjects: 12
Study: 15811983

Group type: EXPERIMENTAL
Intervention: Experimental group (received suicide questions)
Number of subjects: 2342

Group type: EXPERIMENTAL
Intervention: High-risk students in experimental group (received suicide questions)
Number of subjects: 2342
Study: 12520257

Group type: EXPERIMENTAL
Intervention: Dimethylglycine (DMG)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 10869758

Group type: EXPERIMENTAL
Intervention: Conformal radiotherapy (CFRT)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Radial line measurement variation (RLMV) analysis
Number of subjects: 13
Study: 7743619

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 301
Study: 2209294

Group type: EXPERIMENTAL
Intervention: Normal defecation
Number of subjects: 12

Group type: COMPARATOR
Intervention: Voluntary prolonged suppression of defecation
Number of subjects: 12
Study: 7436551

Group type: EXPERIMENTAL
Intervention: Dihydroergotamine and heparin (DHE‐heparin) medication (2500 IU sodium heparin and 0.5 mg DHE, both given subcutaneously twice daily)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Low doses of heparin (5,000 IU of sodium heparin given subcutaneously thrice daily)
Number of subjects: 125
Study: 31826321

Group type: EXPERIMENTAL
Intervention: Prevascularized hydrogel skin grafts
Number of subjects: 5

Group type: COMPARATOR
Intervention: Nonvascularized skin grafts (Control)
Number of subjects: 5
Study: 31066001

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg weekly
Number of subjects: 2932

Group type: EXPERIMENTAL
Intervention: Dupilumab 300 mg every 2 weeks
Number of subjects: 2932

Group type: EXPERIMENTAL
Intervention: Dupilumab combined
Number of subjects: 2932

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2932

Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 2932
Study: 28814332

Group type: EXPERIMENTAL
Intervention: Sarolaner (Simparica®)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Spinosad (Comfortis®)
Number of subjects: 162
Study: 25398970

Group type: EXPERIMENTAL
Intervention: GnRH antagonist protocol (n = 42)
Number of subjects: 83

Group type: COMPARATOR
Intervention: GnRH agonist protocol (n = 41)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Neuroticism (assessed at baseline)
Number of subjects: 83
Study: 24611240

Group type: EXPERIMENTAL
Intervention: Power BalanceT wristband
Number of subjects: 20

Group type: COMPARATOR
Intervention: fake silicone wristband
Number of subjects: 20
Study: 21373274

Group type: EXPERIMENTAL
Intervention: Self-testing of vaginal pH using test gloves, twice a week from 12th to 32nd week of gestation.
Number of subjects: 149082

Group type: COMPARATOR
Intervention: Control group (no self-testing of vaginal pH).
Number of subjects: 149082
Study: 20193613

Group type: EXPERIMENTAL
Intervention: Intranasal glucocorticoid (INGS) for one year
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Specific immunotherapy (SIT) for 4 weeks
Number of subjects: 40

Group type: COMPARATOR
Intervention: Group A (AR patients)
Number of subjects: 40
Study: 17579637

Group type: EXPERIMENTAL
Intervention: 2500 mg calcium diet
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 1200S diet
Number of subjects: 10

Group type: COMPARATOR
Intervention: 400 mg calcium diet
Number of subjects: 10
Study: 15514504

Group type: EXPERIMENTAL
Intervention: Sodium bicarbonate (0.3 g x kg(‐1) with approximately 1 L of water)
Number of subjects: 10
Study: 11754885

Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 648
Study: 9779081

Group type: EXPERIMENTAL
Intervention: 10% xylitol with 1100 ppm F (NaF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: 1100 ppm F (NaF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo dentifrice
Number of subjects: 0
Study: 7942654

Group type: EXPERIMENTAL
Intervention: Sealant applied for 1 minute before composite application
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sealant applied for 2.5 minutes before composite application
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sealant applied for 5 minutes before composite application
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Sealant applied for 10 minutes before composite application
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Two different composites tested
Number of subjects: 80
Study: 3365983

Group type: EXPERIMENTAL
Intervention: Oral contraceptive use with alcohol consumption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral contraceptive use without alcohol consumption
Number of subjects: 0
Study: 31621175

Group type: EXPERIMENTAL
Intervention: GreenLight laser photoselective vaporization of the prostate (GL-PVP)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Bipolar transurethral vaporization of the prostate (bipolar TUVP)
Number of subjects: 119
Study: 30139909

Group type: EXPERIMENTAL
Intervention: Mental health patient portal usage
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Focus groups with patients and family members
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Portal usage data
Number of subjects: 0
Study: 26464468

Group type: EXPERIMENTAL
Intervention: Multiport approach and large working space
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Multiport approach and intermediate working space
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Single-port approach and large working space
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Single-port approach and intermediate working space
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Single-port approach and small working space
Number of subjects: 15

Group type: COMPARATOR
Intervention: Single-port surgery
Number of subjects: 15

Group type: COMPARATOR
Intervention: Multiport surgery
Number of subjects: 15
Study: 24275751

Group type: EXPERIMENTAL
Intervention: Sex-specific chest pain characteristics (CPCs)
Number of subjects: 796
Study: 23623526

Group type: EXPERIMENTAL
Intervention: Lansoprazole (detailed dosage not provided)
Number of subjects: 271
Study: 20598127

Group type: EXPERIMENTAL
Intervention: Guided Internet delivered CBT
Number of subjects: 104

Group type: COMPARATOR
Intervention: Group CBT
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Cost-effectiveness of Internet CBT
Number of subjects: 104
Study: 18166096

Group type: EXPERIMENTAL
Intervention: Periodontal therapy provided by the study
Number of subjects: 303

Group type: COMPARATOR
Intervention: Community dental care
Number of subjects: 303
Study: 16750060

Group type: EXPERIMENTAL
Intervention: Alternating pressure overlay
Number of subjects: 1972

Group type: COMPARATOR
Intervention: Alternating pressure mattress replacement
Number of subjects: 1972

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 1972
Study: 12493134

Group type: EXPERIMENTAL
Intervention: Oral treatments for type II diabetes
Number of subjects: 0
Study: 10742366

Group type: EXPERIMENTAL
Intervention: Theophylline (8 mg/kg)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 8923861

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study: 1410755

Group type: EXPERIMENTAL
Intervention: Lidocaine 2%
Number of subjects: 16

Group type: COMPARATOR
Intervention: Saline infusion (control)
Number of subjects: 16
Study: 3933894

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 31057315

Group type: EXPERIMENTAL
Intervention: Standard diabetes prevention program (DPP) and faith-enhanced DPP
Number of subjects: 221
Study: 29914524

Group type: EXPERIMENTAL
Intervention: Multi-year implementation intervention for AOUD treatment delivery
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Care coordination and psychotherapy for AOUDs
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Screening practices
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Staff training and funding for medications
Number of subjects: 2
Study: 27431258

Group type: EXPERIMENTAL
Intervention: GLP-1
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: GLP-1 + glibenclamide
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32

Group type: COMPARATOR
Intervention: Glibenclamide
Number of subjects: 32
Study: 24516879

Group type: EXPERIMENTAL
Intervention: 20 μg calcifediol daily
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: 140 μg calcifediol weekly
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Single bolus of 140 μg calcifediol
Number of subjects: 35

Group type: COMPARATOR
Intervention: 20 μg vitamin D3 daily
Number of subjects: 35

Group type: COMPARATOR
Intervention: 140 μg vitamin D3 weekly
Number of subjects: 35

Group type: COMPARATOR
Intervention: Single bolus of 140 μg vitamin D3
Number of subjects: 35
Study: 22456624

Group type: EXPERIMENTAL
Intervention: PEG 3 L the day before and 1 L 3h before the procedure (split regimen)
Number of subjects: 336

Group type: COMPARATOR
Intervention: PEG 4 L the afternoon before colonoscopy (full regimen)
Number of subjects: 336
Study: 21047442

Group type: EXPERIMENTAL
Intervention: Guided web-based self-help intervention based on Problem Solving Treatment (PST) for 6 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait list control group
Number of subjects: 0
Study: 17937573

Group type: EXPERIMENTAL
Intervention: Intervention 1: Education and offer of contraceptives at the research clinic
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Intervention 2: Education and offer of contraceptives at the research clinic plus a presentation designed to reduce outside pressures to conceive
Number of subjects: 251

Group type: COMPARATOR
Intervention: Control: Family planning education and referral to an outside clinic for nonbarrier contraceptives
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Injectable contraception among HIV-positive women
Number of subjects: 251
Study: 15208052

Group type: EXPERIMENTAL
Intervention: Mifepristone, 100 mg/day for 2 consecutive days every 30 days, from months 2-7 of implant use
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 12126343

Group type: EXPERIMENTAL
Intervention: Cognitive behaviour therapy along with standard pharmacotherapy
Number of subjects: 10

Group type: COMPARATOR
Intervention: Standard pharmacotherapy alone
Number of subjects: 10
Study: 9830944

Group type: EXPERIMENTAL
Intervention: Snoezelen
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional relaxation approach
Number of subjects: 0
Study: 7857352

Group type: EXPERIMENTAL
Intervention: Pidotimod 800 mg administered orally twice a day for 30 days
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Pidotimod
Number of subjects: 52
Study: 2510263

Group type: EXPERIMENTAL
Intervention: Rioprostil, 200 micrograms b.d.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sucralfate, 1 g t.i.d.
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rioprostil and Sucralfate
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rioprostil
Number of subjects: 30
Study: 31750726

Group type: EXPERIMENTAL
Intervention: Vocal Music Therapy (VMT) program for 12 weeks
Number of subjects: 43

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 43
Study: 29703577

Group type: EXPERIMENTAL
Intervention: Video Interaction Project (VIP)
Number of subjects: 546

Group type: EXPERIMENTAL
Intervention: Building Blocks
Number of subjects: 546

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 546
Study: 28538042

Group type: EXPERIMENTAL
Intervention: Bayley‐III Cognitive Composite score
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Bayley‐III Motor Composite score
Number of subjects: 77

Group type: COMPARATOR
Intervention: BSID‐II MDI
Number of subjects: 77
Study: 26645517

Group type: EXPERIMENTAL
Intervention: Coenzyme Q(10) 100 mg daily for 60 days
Number of subjects: 103

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103
Study: 24274618

Group type: EXPERIMENTAL
Intervention: Short stress management training
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study: 20865874

Group type: EXPERIMENTAL
Intervention: Nitrous oxide
Number of subjects: 100

Group type: COMPARATOR
Intervention: No nitrous oxide
Number of subjects: 100
Study: 18031592

Group type: EXPERIMENTAL
Intervention: Mixed fibre dose (3 g Plantago ovata husk and 1 g glucomannan) twice daily (b.i.d.)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Mixed fibre dose (3 g Plantago ovata husk and 1 g glucomannan) three times daily (t.i.d.)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Mixed fibre dose (b.i.d. and t.i.d.)
Number of subjects: 200
Study: 15963388

Group type: EXPERIMENTAL
Intervention: pioglitazone (45 mg)
Number of subjects: 192

Group type: COMPARATOR
Intervention: glimepiride (1 to 6 mg)
Number of subjects: 192
Study: 12502980

Group type: EXPERIMENTAL
Intervention: Parental presence during induction of anesthesia (PPIA)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: PPIA plus 0.5 mg/kg oral midazolam
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control (no PPIA or midazolam)
Number of subjects: 80
Study: 11022186

Group type: EXPERIMENTAL
Intervention: 1.0 microgram/kg i.v. ALEX
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 2.0 microgram/kg i.v. ALEX
Number of subjects: 6

Group type: COMPARATOR
Intervention: 1.0 microgram/kg i.v. HEX
Number of subjects: 6

Group type: COMPARATOR
Intervention: 2.0 microgram/kg i.v. HEX
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 20mg p.o. ALEX
Number of subjects: 6

Group type: COMPARATOR
Intervention: 20mg p.o. HEX
Number of subjects: 6
Study: 8648837

Group type: COMPARATOR
Intervention: Mitomycin C
Number of subjects: 188

Group type: EXPERIMENTAL
Intervention: Alternating mitomycin C and BCG
Number of subjects: 188
Study: 1803848

Group type: EXPERIMENTAL
Intervention: PTC chewing gum
Number of subjects: 0

Group type: COMPARATOR
Intervention: V6 chewing gum
Number of subjects: 0
Study: 6849739

Group type: EXPERIMENTAL
Intervention: Atenolol (25 mg oral)
Number of subjects: 4

Group type: COMPARATOR
Intervention: Propranolol (40 mg and 50 mg oral)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Isoprenaline (sustained infusion)
Number of subjects: 4
Study: 31924318

Group type: EXPERIMENTAL
Intervention: 8-week educational program
Number of subjects: 198

Group type: COMPARATOR
Intervention: Standard treatment (Control)
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: 8-week educational program (in diabetic patients)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Standard treatment (Control, in diabetic patients)
Number of subjects: 198
Study: 31041925

Group type: EXPERIMENTAL
Intervention: Occupational exposure to low levels of ammonia
Number of subjects: 250

Group type: COMPARATOR
Intervention: Comparison group (office employees)
Number of subjects: 250
Study: 29049282

Group type: EXPERIMENTAL
Intervention: REBOOT intervention (motivational interviewing)
Number of subjects: 63

Group type: COMPARATOR
Intervention: Treatment as usual (information and referrals)
Number of subjects: 63
Study: 27624950

Group type: EXPERIMENTAL
Intervention: REDCap
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: SupportScreen
Number of subjects: 100

Group type: COMPARATOR
Intervention: Paper and pencil
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Computer-based geriatric assessment
Number of subjects: 100
Study: 25140763

Group type: EXPERIMENTAL
Intervention: Muscle Armor™ (MA; Abbott Nutrition, Columbus, OH)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo supplement
Number of subjects: 17
Study: 21946154

Group type: EXPERIMENTAL
Intervention: Protein-glucose solution (8% ¹³C‐enriched glucose and 2% milk protein concentrate)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Glucose only solution
Number of subjects: 8

Group type: COMPARATOR
Intervention: Noncaloric placebo (water)
Number of subjects: 8
Study: 19617584

Group type: EXPERIMENTAL
Intervention: Propofol plus midazolam and/or fentanyl
Number of subjects: 200

Group type: COMPARATOR
Intervention: Propofol alone
Number of subjects: 200
Study: 16651474

Group type: EXPERIMENTAL
Intervention: Chlorthalidone
Number of subjects: 33357

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 33357

Group type: COMPARATOR
Intervention: Lisinopril
Number of subjects: 33357
Study: 12631093

Group type: EXPERIMENTAL
Intervention: Combined therapy (benazepril 10 mg/day + valsartan 80 mg/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Benazepril (20 mg/day)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Valsartan (160 mg/day)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combined therapy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Benazepril
Number of subjects: 24

Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Combined therapy, Benazepril, Valsartan
Number of subjects: 24
Study: 10958820

Group type: EXPERIMENTAL
Intervention: Iron group (Fe), n = 16
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Iron and zinc supplemented group (Fe + Zn), n = 14
Number of subjects: 47

Group type: COMPARATOR
Intervention: Unsupplemented control group (C), n = 17
Number of subjects: 47
Study: 8828241

Group type: EXPERIMENTAL
Intervention: Group delivery of structured relapse prevention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Individual delivery of structured relapse prevention
Number of subjects: 0
Study: 1353102

Group type: EXPERIMENTAL
Intervention: HIVAC-1e vaccine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control vaccinia virus
Number of subjects: 36
Study: 6702866

Group type: EXPERIMENTAL
Intervention: Prazosin (alpha 1-adrenoceptor blockade)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Atenolol (beta 1-adrenoceptor blockade)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Propranolol (nonselective beta-adrenoceptor blockade)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31044424

Group type: EXPERIMENTAL
Intervention: Phenylephrine (100 μg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Noradrenaline (5 μg)
Number of subjects: 90
Study: 28011388

Group type: EXPERIMENTAL
Intervention: Health coaching intervention for 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard-of-care single dietary consultation
Number of subjects: 0
Study: 26951588

Group type: EXPERIMENTAL
Intervention: e‐consultation
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control (traditional referrals)
Number of subjects: 36